热门资讯> 正文
HRTX, MESO and POET are among premarket gainers
2024-04-23 20:48
- Gainers: HWH International (HWH) +37%.
- Smart for Life (SMFL) +32%.
- NKGen Biotech (NKGN) +31%.
- Hibbett (HIBB) +19% to acquire Hibbett in $1.1B deal
- Immunity (IBRX) +18% stock jumps as FDA clears bladder cancer therapy
- SILO Pharma (SILO) +26% Announces Positive Results for Intranasal PTSD Treatment
- AGBA Group Holding (AGBA) +15%.
- Edible Garden (EDBL) +17% regains compliance with Nasdaq bid price requirement
- Oportun Financial (OPRT) +15% Announces Preliminary Q1 2024 Financial Information
- Zhongchao (ZCMD) +13%.
- Cango (CANG) +9% authorizes new $50 million share buyback program
- Gorilla Technology Group (GRRR) +9%.
- Danaher (DHR) +8% gains as Q1 results exceed expectations
- POET Technologies (POET) +7%.
- Wetouch Technology (WETH) +7% Technology grows 2024 revenue by 41%
- Spotify Technology (SPOT) +7% rises as premium subscribers grow in Q1, despite lower than expected monthly users
- WiSA Technologies (WISA) +6%.
- Mesoblast (MESO) +6%.
- PENN Entertainment (PENN) +6% Names Aaron LaBerge Chief Technology Officer
- SES AI Corporation (SES) +6% Announces its May 2024 Event Calendar
- Heron Therapeutics (HRTX) +5%.
- Kimberly-Clark (KMB) +5% Q1 earnings call release
More on premarket gainers & stock
- Heron Therapeutics: Zynrelef Potentially Eases Shareholder Pain
- Mesoblast Limited: Back From The Dead
- Heron Therapeutics, Inc. 2023 Q4 - Results - Earnings Call Presentation
- Mesoblast gains as FDA backs regulatory plans for cell therapy
- Heron Therapeutics Q4 2023 Earnings Preview
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。